The ‘blended’ bioanalytical laboratory: the marriage of antibody- and instrument-based methods and expertise
The need for serological markers of response to vitamin D status optimization: a case for quantitative serum proteomics
Scientists develop new biosensor to test for Alzheimer's disease
MS imaging for cancer tissue analysis
The smart way to test for cholesterol
Assay could predict suspect's gender at the scene of a crime
Ethyl glucuronide is found to be a promising long-term alcohol biomarker
Conference Report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF
The importance of partnership when outsourcing exploratory bioanalysis
Validation of a method for quantifying enzalutamide and its major metabolites in human plasma by LC–MS/MS
A clinical biomarker assay for the quantification of d3-creatinine and creatinine using LC–MS/MS
Matrix effects in metabolite quantification for MIST assessment: the impact of phospholipid removal and HPLC column particle size
Alternative strategies for mass spectrometer-based sample dilution of bioanalytical samples, with particular reference to DBS and plasma analysis
Evaluation of horse urine sample preparation methods for metabolomics using LC coupled to HRMS
Accurate weighing and dilution-assisted plasma microsampling (AWADA-PM): an easy-to-implement and rugged strategy
Recent advances in forensic drug analysis by DART-MS
Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis
Application and challenges in using LC–MS assays for absolute quantitative analysis of therapeutic proteins in drug discovery
Advances in the detection of designer steroids in anti-doping